Presidency
Paolo A. Ascierto, Director of Melanoma. Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Naples, Italy
Bernard A. Fox, Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Center Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US
Rational
After decades of research and clinical trials, vaccines are beginning to impact patient out- comes. While the future is bright, we still have a long way to go.
This event will be an international meeting for experts to share and discuss the latest findings and future perspectives on cancer vaccines. The objectives of the conference are to:
- Present up-to-date data.
- Interpret clinical and scientific findings and predict potential impact.
- Recognize and characterize the hurdles that remain.
- Provide a vision for the future if hurdles are addressed
There will be panel discussions embedded in each session to address questions raised by presentations, allow time to consider visions for the future, identify the hurdles that remain, and summarize areas of consensus and/or disagreement.
Organizational Secretariat
Informazioni
- October 1st, 2024
-
NH COLLECTION MILANO CITYLIFE
Via Bartolomeo Colleoni,14 20149 Milan, ITALY